Quest Diagnostics SVP & general counsel sells $5.5m in shares
Covered in this story
What has happened since
- Quest Diagnostics is down 1.9% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Quest Diagnostics
- Truist Securities: $228 → $250 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quest Diagnostics →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.